Zobrazeno 1 - 10
of 282
pro vyhledávání: '"Campone, Mario"'
Autor:
Nocquet L; INSERM, CNRS, CRCI2NA, Université de Nantes, 44000, Nantes, France.; Equipe Labellisée LIGUE Contre le Cancer, Paris, France.; SIRIC ILIAD, Nantes, Angers, France., Roul J; INSERM, CNRS, CRCI2NA, Université de Nantes, 44000, Nantes, France.; Equipe Labellisée LIGUE Contre le Cancer, Paris, France.; SIRIC ILIAD, Nantes, Angers, France.; ICO René Gauducheau, Saint Herblain, France., Lefebvre CC; INSERM, CNRS, CRCI2NA, Université de Nantes, 44000, Nantes, France.; Equipe Labellisée LIGUE Contre le Cancer, Paris, France.; SIRIC ILIAD, Nantes, Angers, France., Duarte L; INSERM, CNRS, CRCI2NA, Université de Nantes, 44000, Nantes, France.; Equipe Labellisée LIGUE Contre le Cancer, Paris, France.; SIRIC ILIAD, Nantes, Angers, France., Campone M; INSERM, CNRS, CRCI2NA, Université de Nantes, 44000, Nantes, France.; SIRIC ILIAD, Nantes, Angers, France.; ICO René Gauducheau, Saint Herblain, France., Juin PP; INSERM, CNRS, CRCI2NA, Université de Nantes, 44000, Nantes, France. philippe.juin@univ-nantes.fr.; Equipe Labellisée LIGUE Contre le Cancer, Paris, France. philippe.juin@univ-nantes.fr.; SIRIC ILIAD, Nantes, Angers, France. philippe.juin@univ-nantes.fr.; ICO René Gauducheau, Saint Herblain, France. philippe.juin@univ-nantes.fr., Souazé F; INSERM, CNRS, CRCI2NA, Université de Nantes, 44000, Nantes, France. frederique.souaze@univ-nantes.fr.; Equipe Labellisée LIGUE Contre le Cancer, Paris, France. frederique.souaze@univ-nantes.fr.; SIRIC ILIAD, Nantes, Angers, France. frederique.souaze@univ-nantes.fr.
Publikováno v:
Scientific reports [Sci Rep] 2024 Jun 19; Vol. 14 (1), pp. 14177. Date of Electronic Publication: 2024 Jun 19.
Autor:
Ginzac A; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France. angeline.ginzac@clermont.unicancer.fr.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France. angeline.ginzac@clermont.unicancer.fr.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France. angeline.ginzac@clermont.unicancer.fr., Molnar I; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France., Durando X; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France.; Service d'oncologie médicale, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France., Motte Rouge T; Service d'oncologie médicale, Centre Eugène MARQUIS, Rennes, France., Petit T; Service d'oncologie médicale, Institut de Cancérologie Strasbourg Europe, Strasbourg, France., D'hondt V; Service d'oncologie médicale, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier, France., Campone M; Service d'oncologie médicale, Institut de Cancérologie de l'Ouest, René GAUDUCHEAU, Saint Herblain, France., Bonichon-Lamichhane N; Service d'oncologie médicale et radiothérapie, Clinique Tivoli, Bordeaux, France., Venat Bouvet L; Service d'oncologie médicale, CHU Dupuytren, Limoges, France., Levy C; Service d'oncologie médicale, Centre François BACLESSE, Caen, France., Augereau P; Service d'oncologie médicale, Institut de Cancérologie de l'Ouest, René GAUDUCHEAU, Saint Herblain, France., Pistilli B; Service d'oncologie médicale, Institut Gustave ROUSSY, Villejuif, France., Arsene O; Service d'oncologie médicale, Centre Hospitalier de Blois, Blois, France., Jouannaud C; Service d'oncologie médicale, Institut Jean GODINOT, Reims, France., Nguyen S; Service d'oncologie médicale, Centre Hospitalier de Pau, Pau, France., Cayre A; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France., Tixier L; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France., Mahier Ait Oukhatar C; Unicancer, Paris, France., Nabholtz JM; Centre d'oncologie, Université King Saud (Medical City), Riyadh, Arabi Saoudite., Penault-Llorca F; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France., Mouret-Reynier MA; Service d'oncologie médicale, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jun; Vol. 205 (2), pp. 267-279. Date of Electronic Publication: 2024 Mar 07.
Autor:
Giacchetti S; AP-HP, Hôpital Saint Louis, Senologie, Paris and Chronotherapy, Cancers, and Transplantation Unit, Faculty of Medicine, Paris-Saclay University, France; Chronotherapy, Cancers and Transplatation Unit, Faculty of Medicine, Paris-Saclay, Villejuif, France. Electronic address: sylvie.giacchetti@aphp.fr., Laas E; Surgery Department, Institut Curie, Universite Paris Cite, Paris, France; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France., Bachelot T; Medical Oncology, Centre Leon Berard, Lyon, France., Lemonnier J; R&D Unicancer, Paris, France., André F; Gustave Roussy, Villejuif, France., Cameron D; ICR-CTSU, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Bliss J; Medical Oncology, Western General Hospital, Edinburgh, United Kingdom., Chabaud S; Department of Clinical Research and Innovation, Centre Leon Berard, Lyon, France., Hardy-Bessard AC; Medical Oncology, CARIO, Plerin, France., Lacroix-Triki M; Gustave Roussy, Villejuif, France., Canon JL; Medical Oncology, Grand Hopital de Charleroi, Charleroi, Belgium., Debled M; Medical Oncology, Institut Bergonie, Bordeaux, France., Campone M; Medical Oncology, Institut Cancerologie de l'Ouest, Saint Herblain, France., Cottu P; Medical Oncology, Institut Curie, Universite Paris Cite, Paris, France., Dalenc F; Medical Oncology, Oncopole Claudius Regaud, IUCT, Toulouse, France., Ballesta A; U900, Institut Curie, Saint Cloud, France., Penault-Llorca F; Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, Clermont Ferrand, France., Asselain B; Arcagy-Gineco, Paris, France., Dumas E; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France; Department of Mathematics, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; (t)'Chronotherapy, Cancers, and Transplantation' Unit, Faculty of Medicine, Paris-Saclay University, Villejuif, France., Reyal F; Surgery Department, Institut Curie, Universite Paris Cite, Paris, France; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France., Gougis P; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France., Lévi F; Chronotherapy, Cancers and Transplatation Unit, Faculty of Medicine, Paris-Saclay, Villejuif, France., Hamy AS; Medical Oncology, Institut Curie, Universite Paris Cite, Paris, France; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France.
Publikováno v:
EBioMedicine [EBioMedicine] 2024 Jun; Vol. 104, pp. 105141. Date of Electronic Publication: 2024 May 07.
Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
Autor:
Zhou K; Department of Human and Social Sciences, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France., Robert M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France., Seegers V; Department of Biostatistics, Institut de Cancérologie de l'Ouest, St-Herblain, France., Blanc-Lapierre A; Department of Biostatistics, Institut de Cancérologie de l'Ouest, St-Herblain, France., Savouroux S; Department of Health Promotion and Prevention, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France., Bigot F; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Angers, France., Frenel JS; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France., Campone M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France., Conroy T; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France., Penault-Llorca F; Department of Biopathology and INSERM U1240, Centre Jean Perrin, Clermont-Ferrand, France., Raoul JL; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France., Bellanger MM; Department of Human and Social Sciences, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France.; Department of Health Promotion and Prevention, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France.
Publikováno v:
PloS one [PLoS One] 2024 May 31; Vol. 19 (5), pp. e0304556. Date of Electronic Publication: 2024 May 31 (Print Publication: 2024).
Autor:
Jézéquel P; Institut de Cancérologie de l'Ouest, 44805, Saint Herblain, France. pascal.jezequel@ico.unicancer.fr.; Nantes Université, Univ Angers, INSERM, CNRS, CRCI2NA, 44000, Nantes, France. pascal.jezequel@ico.unicancer.fr.; Équipe Labellisée LIGUE Contre Le Cancer CRCI2NA, 44000, Nantes, France. pascal.jezequel@ico.unicancer.fr., Lasla H; Institut de Cancérologie de l'Ouest, 44805, Saint Herblain, France., Gouraud W; Institut de Cancérologie de l'Ouest, 44805, Saint Herblain, France., Basseville A; Institut de Cancérologie de l'Ouest, 44805, Saint Herblain, France., Michel B; Nantes Université, École Centrale Nantes, CNRS, Laboratoire de Mathématiques Jean Leray, LMJL, UMR 6629, 44000, Nantes, France., Frenel JS; Institut de Cancérologie de l'Ouest, 44805, Saint Herblain, France.; Nantes Université, Univ Angers, INSERM, CNRS, CRCI2NA, 44000, Nantes, France.; Équipe Labellisée LIGUE Contre Le Cancer CRCI2NA, 44000, Nantes, France., Juin PP; Nantes Université, Univ Angers, INSERM, CNRS, CRCI2NA, 44000, Nantes, France.; Équipe Labellisée LIGUE Contre Le Cancer CRCI2NA, 44000, Nantes, France., Ben Azzouz F; Institut de Cancérologie de l'Ouest, 44805, Saint Herblain, France., Campone M; Institut de Cancérologie de l'Ouest, 44805, Saint Herblain, France.; Nantes Université, Univ Angers, INSERM, CNRS, CRCI2NA, 44000, Nantes, France.; Équipe Labellisée LIGUE Contre Le Cancer CRCI2NA, 44000, Nantes, France.; Université d'Angers, 49000, Angers, France.
Publikováno v:
Breast cancer (Tokyo, Japan) [Breast Cancer] 2024 May 22. Date of Electronic Publication: 2024 May 22.
Autor:
Goetz MP; Mayo Clinic, Rochester, Minnesota., Hamilton EP; Sarah Cannon Research Institute, Tennessee Oncology PLCC, Nashville, Tennessee., Campone M; Institut de Cancerologie de l'Ouest, Angers Cedex, France., Hurvitz SA; University of California, Los Angeles, California., Cortes J; Oncology Department, International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Department of Medicine, Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Madrid, Spain., Johnston S; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Llombart-Cussac A; Hospital Arnau Vilanova, Valencia, Spain., Kaufman PA; University of Vermont Medical Center, Burlington, Vermont., Toi M; Kyoto University, Kyoto, Japan., Jerusalem G; CHU Liege and Liege University, Liege, Belgium., Graham H; Eli Lilly and Company, Indianapolis, Indiana., Wang H; Eli Lilly and Company, Indianapolis, Indiana., Jansen VM; Eli Lilly and Company, Indianapolis, Indiana., Litchfield LM; Eli Lilly and Company, Indianapolis, Indiana., Martin M; Instiuto de Investigacion Santaria Gregorio Maranon, Universidad Complutense, CIBERONC, Madrid, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2233-2244.
Autor:
Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. hope.rugo@ucsf.edu.; Department of Medicine (Hematology/Oncology), University of California San Francisco Helen Diller Family Comprehensive Cancer Center, 1825 4th St., 3rd Floor, San Francisco, CA, 94158, USA. hope.rugo@ucsf.edu., Van Poznak CH; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA., Neven P; University Hospitals Leuven, Louvain, Belgium., Danielewicz I; Szpital Morski Im. PCK, Gdynia, Poland., Lee SC; National University Hospital (S) Pte Ltd, Singapore, Singapore., Campone M; Institut de Cancerologie de l'Ouest, St Herblain, France., Chik JYK; Queen Elizabeth Hospital, Kowloon, Hong Kong., Vega Alonso E; Centro Integral Oncológico Clara Campal, Madrid, Spain., Naume B; Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Oslo, Norway., Brain E; Institut Curie - René-Huguenin Hospital, Saint-Cloud, France., Siegel JM; Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA., Li R; Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA., Uema D; Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA., Wagner VJ; Bayer Consumer Care AG, Basel, Switzerland., Coleman RE; Cancer Clinical Trials Centre, University of Sheffield, Weston Park Hospital, Sheffield, UK. r.e.coleman@sheffield.ac.uk.; Department of Oncology and Metabolism, Cancer Clinical Trials Centre, Weston Park Hospital, Broomcross Building, Floor 2, Whitham Road, Sheffield, S10 2SJ, UK. r.e.coleman@sheffield.ac.uk.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Apr; Vol. 204 (2), pp. 249-259. Date of Electronic Publication: 2023 Dec 20.
Autor:
Vanacker H; Centre Léon Bérard, Lyon, France., Treilleux I; Centre Léon Bérard, Lyon, France., Schiffler C; Centre Léon Bérard, Lyon, France., Bieche I; Institut Curie, Paris, France., Campone M; Institut de cancérologie de l'ouest Pays de Loire Nantes-Angers, Saint-Herblain, France., Patsouris A; Institut de cancérologie de l'ouest Pays de Loire Nantes-Angers, Saint-Herblain, France., Arnedos M; Gustave Roussy, Villejuif, France., Cottu PH; Institut Curie, Paris, France., Jacquin JP; Institut de Cancérologie Lucien Neuwirth, Saint-Priest-En-Jarez, France., Dalenc F; ICR, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France., Pinton A; Institut Curie, Paris, France., Servant N; Institut Curie, Paris, France., Attignon V; Centre Léon Bérard, Lyon, France., Rouleau E; Gustave Roussy, Villejuif, France., Morel A; Institut de cancérologie de l'ouest Pays de Loire Nantes-Angers, Saint-Herblain, France.; Univ Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, F-49000, Angers, France., Legrand F; UNICANCER R&D, Paris, France., Jimenez M; UNICANCER R&D, Paris, France., Andre F; Gustave Roussy, Villejuif, France., Bachelot T; Centre Léon Bérard, Lyon, France. thomas.bachelot@lyon.unicancer.fr.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Mar; Vol. 130 (4), pp. 613-619. Date of Electronic Publication: 2024 Jan 05.
Autor:
García-Lorenzo B; Biosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Spain., Gorostiza A; Biosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Spain., Alayo I; Biosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Spain., Castelo Zas S; Osakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Innovation and Quality Assistant Service, Barakaldo-Bizkaia, Spain., Cobos Baena P; Osakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Mammary Pathology Service, Barakaldo-Bizkaia, Spain., Gallego Camiña I; Osakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Innovation and Quality Assistant Service, Barakaldo-Bizkaia, Spain., Izaguirre Narbaiza B; Osakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Analytical Accounting, Economic and Financial Directorate, Barakaldo, Spain., Mallabiabarrena G; Osakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Mammary Pathology Service, Barakaldo-Bizkaia, Spain., Ustarroz-Aguirre I; Osakidetza Basque Health Service, Ezkerraldea Enkarterri Cruces Integrated Health Organisation, Economic Evaluation Unit, Economic and Financial Directorate, Barakaldo, Spain., Rigabert A; Fundación Andaluza Beturia para la Investigación en Salud (FABIS), Huelva, Spain., Balzi W; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Maltoni R; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Massa I; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Álvarez López I; Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Medical Oncology, Donostia, Spain.; Biodonostia, Donostia, Gipuzkoa, Spain., Arévalo Lobera S; Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Medical Oncology, Donostia, Spain.; Biodonostia, Donostia, Gipuzkoa, Spain., Esteban M; Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Economic Resource Service, Donostia, Gipuzkoa, Spain., Fernández Calleja M; Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Mamary Pathology Service, Donostia, Gipuzkoa, Spain., Gómez Mediavilla J; Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Medical Oncology, Donostia, Spain., Fernández M; Osakidetza Basque Health Service, Donostialdea Integrated Health Organisation, Economic Resource Service, Donostia, Gipuzkoa, Spain., Del Oro Hitar M; Gynecology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Hospital Universitario 12 de Octubre, Madrid, Spain., Ortega Torres MDC; Gynecology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Hospital Universitario 12 de Octubre, Madrid, Spain., Sanz Ferrandez MC; Gynecology Department, Hospital Universitario 12 de Octubre, Madrid, Spain., Manso Sánchez L; Hospital Universitario 12 de Octubre, Madrid, Spain.; Instituto de Investigación Biomédica del Hospital Universitario 12 de Octubre, Madrid, Spain., Serrano Balazote P; Hospital Universitario 12 de Octubre, Madrid, Spain.; Instituto de Investigación Biomédica del Hospital Universitario 12 de Octubre, Madrid, Spain., Varela Rodríguez C; Hospital Universitario 12 de Octubre, Madrid, Spain.; Instituto de Investigación Biomédica del Hospital Universitario 12 de Octubre, Madrid, Spain., Campone M; Institut de Cancérologie de l'Ouest, Angers-Nantes, France., Le Lann S; Institut de Cancérologie de l'Ouest, Angers-Nantes, France., Vercauter P; Department of Pulmonary Medicine, Onze-Lieve-Vrouw Hospital, Aalst, Belgium., Tournoy K; Department of Pulmonary Medicine, Onze-Lieve-Vrouw Hospital, Aalst, Belgium.; Faculty of Medicine and Life Sciences, Ghent University, Ghent, Belgium., Borges M; Instituto Português de Oncologia do Porto, Portugal., Oliveira AS; Instituto Português de Oncologia do Porto, Portugal., Soares M; Instituto Português de Oncologia do Porto, Portugal., Fullaondo A; Biosistemak Institute for Health Systems Research, Torre del Bilbao Exhibition Centre, Barakaldo, Spain.
Publikováno v:
European journal of public health [Eur J Public Health] 2024 Feb 05; Vol. 34 (1), pp. 44-51.
Autor:
Dupoiron D; Department of Anesthesiology and Pain Medicine, Institut de Cancerologie de l'Ouest, Angers, France. denis.dupoiron@ico.unicancer.fr., Autier L; Department of Medical Oncology, Institut de Cancerologie de l'Ouest, Angers, France., Lebrec N; Department of Anesthesiology and Pain Medicine, Institut de Cancerologie de l'Ouest, Angers, France., Seegers V; Department of Epidemiology and Biostatistics, Institut de Cancerologie de l'Ouest, Angers, France., Folliard C; Department of Pharmacy, Institut de Cancerologie de l'Ouest, Angers, France., Patsouris A; Department of Medical Oncology, Institut de Cancerologie de l'Ouest, Angers, France., Campone M; Department of Medical Oncology, Institut de Cancerologie de l'Ouest, Angers, France., Augereau P; Department of Medical Oncology, Institut de Cancerologie de l'Ouest, Angers, France.
Publikováno v:
Journal of breast cancer [J Breast Cancer] 2023 Dec; Vol. 26 (6), pp. 572-581. Date of Electronic Publication: 2023 Sep 08.